2025 Snow Vision Accelerator Annual Conference

2025 Snow Vision Accelerator Annual Conference

Snow Vision Accelerator Annual Conference: A Bold Step Toward Transforming Vision Health

On 1–2 December 2025, the Snow Vision Accelerator Advisory Committee hosted the inaugural Snow Vision Accelerator Annual Conference at the University of Sydney — a landmark event bringing together leading scientists, clinicians, industry partners, and philanthropists to accelerate progress in vision research. With over 85 attendees, including members of the Advisory Committee chaired by Professor Ian Constable AO, the conference showcased the power of collaboration and long-term investment in tackling some of the most pressing challenges in eye health.

The Snow Vision Accelerator is built on a bold philosophy: to do things differently. This initiative represents a step-change in how research is funded and delivered — moving beyond traditional grants to build systems, platforms, and ecosystems that enable impact at scale. At the heart of this approach is a true partnership between Snow Medical and the University of Sydney, combining world-class capability with long-term philanthropic investment to give scientists both the tools and freedom to pursue real-world outcomes.

The principles that underpin Snow Medical’s vision:

  • Excellence without compromise — no tolerance for mediocrity or unnecessary bureaucracy.
  • Boldness and audacity — meaningful progress requires ambition and measured risk.
  • Integrity — ethical science, free of ego and territorialism.
  • Entrepreneurial discipline — speed with rigour to translate discoveries to the bedside.
  • Diversity and inclusion — because better diversity drives better results.

It was an early first step, in creating a relationship between the Advisory Committee and the scientists and developing the research trajectory for the next year and beyond. Over two days, researchers presented cutting-edge work across major programs, engaged in open discussions about successes and setbacks, and worked with advisors to shape the next phase of research.